Question 1

Does UBS Group own PRQR stock?

Accepted Answer

Yes. As of its Q2 2026 13F, UBS Group holds 639,243 shares of PRQR (ProQR Therapeutics), worth $1.2M.

Question 2

How many shares of PRQR does UBS Group own?

Accepted Answer

As of its Q2 2026 13F, UBS Group holds 639,243 shares of PRQR (ProQR Therapeutics).

Question 3

What is UBS Group's PRQR position worth?

Accepted Answer

As of its Q2 2026 13F, UBS Group's PRQR position is worth $1.2M.

Question 4

Is UBS Group buying or selling PRQR?

Accepted Answer

In Q2 2026, UBS Group increased its PRQR position by 333,979 shares (+109.4%).

Question 5

When did UBS Group first buy PRQR?

Accepted Answer

UBS Group first reported PRQR in its Q2 2019 13F and has listed it in 27 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	639,243	+109.4%	$1.2M	0.0%	$1.86	41
2026-Q1	Decreased	305,264	-61.7%	$494,528	0.0%	$1.62	0
2025-Q4	Increased	797,664	+743.6%	$1.6M	0.0%	$2.02	41
2025-Q3	Decreased	94,550	-91.7%	$201,391	0.0%	$2.13	0
2025-Q2	Decreased	1.1M	-36.0%	$2.3M	0.0%	$2.04	0
2025-Q1	Decreased	1.8M	-22.6%	$2.4M	0.0%	$1.33	0
2024-Q4	Increased	2.3M	+796x	$6.1M	0.0%	$2.65	44
2024-Q3	Decreased	2,900	-89.5%	$5,278	0.0%	$1.83	0